AdJane is a clinical-stage vaccine platform company utilizing its native Outer Membrane Vesicle (nOMV) platform to address pandemic preparedness, antimicrobial resistance, and global health challenges. AdJane’s platform has been scientifically developed over 30 years by leading Dutch governmental research institutions. The company’s next-generation platform enables rapid vaccine development through three distinct deployment modalities and supports both prophylactic and therapeutic applications. Visit www.adjane.com.

AdJane BioSciences

Org chart

Teams

Offices